Carnegie Investment Counsel Purchases New Holdings in Synopsys, Inc. $SNPS

Carnegie Investment Counsel acquired a new stake in Synopsys, Inc. (NASDAQ:SNPS) in the 3rd quarter, Holdings Channel.com reports. The fund acquired 38,904 shares of the semiconductor company’s stock, valued at approximately $19,195,000.

Several other institutional investors and hedge funds have also modified their holdings of SNPS. Norges Bank bought a new position in shares of Synopsys in the 2nd quarter valued at $647,964,000. Ameriprise Financial Inc. grew its position in Synopsys by 29.1% during the 2nd quarter. Ameriprise Financial Inc. now owns 2,598,874 shares of the semiconductor company’s stock worth $1,333,095,000 after acquiring an additional 585,494 shares during the last quarter. Generation Investment Management LLP acquired a new position in Synopsys in the 1st quarter worth about $240,491,000. Aspex Management HK Ltd raised its position in Synopsys by 106.0% in the second quarter. Aspex Management HK Ltd now owns 645,895 shares of the semiconductor company’s stock valued at $331,137,000 after purchasing an additional 332,364 shares during the last quarter. Finally, Alliancebernstein L.P. boosted its stake in shares of Synopsys by 22.2% during the first quarter. Alliancebernstein L.P. now owns 1,725,211 shares of the semiconductor company’s stock valued at $739,857,000 after purchasing an additional 313,218 shares in the last quarter. 85.47% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of equities analysts have recently commented on the stock. JPMorgan Chase & Co. lifted their price target on shares of Synopsys from $600.00 to $650.00 and gave the stock an “overweight” rating in a report on Thursday, December 11th. The Goldman Sachs Group reduced their price target on Synopsys from $700.00 to $600.00 and set a “buy” rating on the stock in a research report on Wednesday, September 10th. Piper Sandler lowered their price objective on Synopsys from $630.00 to $602.00 and set an “overweight” rating for the company in a research report on Thursday, December 11th. Wells Fargo & Company upped their target price on Synopsys from $445.00 to $500.00 and gave the company an “equal weight” rating in a report on Thursday, December 11th. Finally, Robert W. Baird restated a “neutral” rating and set a $535.00 price target (down previously from $670.00) on shares of Synopsys in a report on Wednesday, September 10th. Eleven research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $562.13.

Synopsys Trading Up 0.3%

NASDAQ:SNPS opened at $477.14 on Friday. Synopsys, Inc. has a 52 week low of $365.74 and a 52 week high of $651.73. The firm has a 50-day moving average price of $437.58 and a two-hundred day moving average price of $503.61. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.52 and a current ratio of 1.62. The firm has a market cap of $91.29 billion, a price-to-earnings ratio of 59.72, a price-to-earnings-growth ratio of 3.96 and a beta of 1.16.

Synopsys (NASDAQ:SNPS) last released its earnings results on Wednesday, December 10th. The semiconductor company reported $2.90 EPS for the quarter, topping analysts’ consensus estimates of $2.79 by $0.11. The company had revenue of $2.25 billion for the quarter, compared to analysts’ expectations of $2.25 billion. Synopsys had a return on equity of 7.89% and a net margin of 18.89%.The business’s revenue for the quarter was up 37.8% compared to the same quarter last year. During the same period in the previous year, the business posted $3.40 EPS. Synopsys has set its FY 2026 guidance at 14.320-14.400 EPS and its Q1 2026 guidance at 3.520-3.580 EPS. On average, equities analysts expect that Synopsys, Inc. will post 10.64 earnings per share for the current fiscal year.

Key Headlines Impacting Synopsys

Here are the key news stories impacting Synopsys this week:

• Positive Sentiment: Analysts/commentary note Synopsys’ recent bounce and argue the shares could be attractive after the pullback; these narratives can support buying interest as investors re-evaluate valuation and growth prospects. Is Synopsys (SNPS) an Attractive Investment Choice?
• Positive Sentiment: Separate coverage focuses on an ~18% share rebound, asking whether the recovery leaves the stock undervalued — this kind of coverage can support momentum buyers. Synopsys (SNPS): Has the Recent 18% Share Price Rebound Left the Stock Undervalued?
• Neutral Sentiment: Reported short-interest data appears to show a 0-share figure and 0.0 days-to-cover — likely a data glitch and not a reliable signal for positioning. Treat this as non-actionable until confirmed by an exchange/shorts report.
• Negative Sentiment: Multiple law firms have announced class-action suits or investor alerts alleging securities fraud tied to a sharp prior stock drop; firms are soliciting lead plaintiffs with a looming Dec. 30, 2025 deadline. The alleged class period is Dec. 4, 2024 through Sept. 9, 2025; some filings cite a ~36% decline as the basis for claims. This concentrated legal publicity increases headline risk, potential litigation costs, and investor uncertainty — factors that can pressure the stock. Representative notices: KSF / Charles Foti 96-Hour Deadline Alert — BFA: Suit after 36% stock drop — Levi & Korsinsky notice

Insider Activity at Synopsys

In related news, CFO Shelagh Glaser sold 3,657 shares of the firm’s stock in a transaction that occurred on Friday, December 19th. The shares were sold at an average price of $460.77, for a total value of $1,685,035.89. Following the completion of the transaction, the chief financial officer directly owned 17,842 shares of the company’s stock, valued at approximately $8,221,058.34. This trade represents a 17.01% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 0.62% of the company’s stock.

Synopsys Company Profile

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.